Aude Marie Savoye

Final results from a phase III randomized clinical trial of adjuvant endocrine therapy ± chemotherapy in women ≥ 70 years old with ER+ HER2- breast cancer and a high genomic grade index: The Unicancer ASTER 70s trial.

Étienne Brain, A.A. Viansone, Emmanuelle Bourbouloux et al. · Journal of Clinical Oncology · 2022 · 34 citations

Medicine, Endocrinology, Oncology +15

EWOC-1: A randomized trial to evaluate the feasibility of three different first-line chemotherapy regimens for vulnerable elderly women with ovarian cancer (OC): A GCIG-ENGOT-GINECO study.

Claire Falandry, Aude Marie Savoye, Laëtitia Stefani et al. · Journal of Clinical Oncology · 2019 · 27 citations

Medicine, Gynecology, Oncology +17

Efficacy and safety results from neopembrov study, a randomized phase II trial of neoadjuvant chemotherapy (CT) with or without pembrolizumab (P) followed by interval debulking surgery and standard systemic therapy ± P for advanced high-grade serous carcinoma (HGSC): A GINECO study.

Isabelle Laure Ray-Coquard, Aude Marie Savoye, Marie‐Ange Mouret‐Reynier et al. · Journal of Clinical Oncology · 2021 · 12 citations

Medicine, Oncology, Surgery +14